NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

And, if you take it one more step, IDH can transition. Once transitioned from proneural, it will be useful to see if some thereafter responded more readily to treatment. It’s a very very small group, and as Dr. Ashkan emphasized....Yes, we know some subtypes respond more than others, but it works for everyone (in his opinion).

You can still learn a great deal without the blind. The blind was done serving its purpose many months ago, IMO,

One other thing people forget, there was a German dendritic trial, where cured patients started presenting benign tumors over a decade later. Come to find, the immune system was shown to be still active against cancer, and, like a super cop, still vigilant against mutations many years down the road, thus isolating and encapsulating any further mutation threats.

I’m duly impressed with the immune system’s memory. A couple weeks ago I read an article that tetanus shots could allow the immune system to mount a viable response to infection up to sixty years after inoculation.